Chris Markoch: Page 10
Want to write for BIZ Experiences too? Apply to join BIZ Experiences Leadership network.
Latest: Page 10
AbbVie Has a Mixed Outlook After Mixed Earnings
AbbVie stock was up after posting a mixed fourth-quarter earnings report, but with the company's patent expiring on Humira, the stock is a hold
Enphase Energy May be Offering Investors a Second Chance
For opportunistic investors, the recent drop in ENPH stock may be a buying opportunity before the stock makes another run to an all-time high
Should Investors Buy or Sell the Vaccinex Patent News?
Shares of Vaccinex, Inc. are higher on February 7 on news that the clinical-stage biotechnology company secured a patent. Is it time to buy or sell the news?
Is Merck Stock a Buy After Its Post-Earnings Sell-Off?
Despite beating analysts' expectations on the top and bottom lines, MRK stock fell after earnings. This article analyzes if investors should jump in
Zimmer Biomet Beats on Earnings, Growth May be Priced In
Zimmer Biomet stock is gaining after beating expectations. However, ZBH stock was fairly valued before earnings meaning investors may need to wait on analysts
Bright Green Corporation Future May be Getting Brighter
Shares of Bright Green Corporation have moved sharply higher after the company announced a funding agreement, but this penny stock may still carry some risk
